
|Articles|August 2, 2015
Ongoing Debate Over High Cost Cholesterol Drugs Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/ongoing-debate-over-high-cost-cholesterol-drugs-hi" target="_blank">View the story "Ongoing Debate Over High Cost Cholesterol Drugs Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
2
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
3
E4 Did Not Significantly Impact Blood Pressure in Postmenopausal Women Receiving Treatment for VMS
4
Immunization and Vigilance: Preventing Infections in T-Cell Modifying Therapies
5
















































































































































































































